United States · Series C startup
10 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$146Mraised across 10 rounds since 2007, from 10 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
RA Capital Management
Perceptive Advisors
Redmile Group
Aju IB Investment
venBio Partners
Jennison Associates
Ridgeway Management HoldingsFrom a historical funding recordSEC filing: $94M sold, first sale Aug 2014
From a historical funding recordSEC filing: $20M sold, first sale Nov 2011
Reported by finsmes.comSEC filing: $20M sold, first sale Nov 2011
No investor was named in the report.
From a historical funding recordSEC filing: $1.2M sold, first sale Sept 2010
No investor was named in the report.
Reported by bellicum.comSEC filing: $1.3M sold, first sale Oct 2009
No investor was named in the report.
From a historical funding recordSEC filing: $1.3M sold, first sale Oct 2009
No investor was named in the report.
From a historical funding recordSEC filing: $500K sold, first sale Mar 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
RA Capital ManagementPerceptive AdvisorsRedmile GroupAju IB InvestmentvenBio PartnersThe Texas Emerging Technology FundJennison AssociatesSabby CapitalMissing a round, or an investor who was in one? Tell us.
Bellicum Pharmaceuticals's investors include Remeditex Ventures, AVG Ventures, RA Capital Management, Perceptive Advisors and Redmile Group, and 8 more on record.
Bellicum Pharmaceuticals has raised $146M across 10 rounds since 2007.
Bellicum Pharmaceuticals's most recent round was a Series C of $94M in Aug 2014.
Its most recent round, $94M in Aug 2014, is also its largest on record.
Bellicum Pharmaceuticals's first round on record, in Oct 2007, was backed by The Texas Emerging Technology Fund.
Bellicum Pharmaceuticals's latest named round is a Series C, in Aug 2014.
Bellicum Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·